Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
300760
株式のランク
#790
Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.... Operating on a global scale, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. specializes in providing a comprehensive range of medical devices and innovative healthcare solutions. Its extensive portfolio encompasses several key segments. Within patient monitoring and life support, the company manufactures crucial equipment such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, and endoscopes, along with associated accessories. This segment also delivers integrated solutions for emergency care, peri-operative management, critical care, and medical IT systems. For in-vitro diagnostics, Mindray offers sophisticated products including hematology and chemistry analyzers and their reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry instruments, and microplate readers and washers. These are further supported by solutions tailored for coagulation, urinalysis, and microbiology. The company additionally produces advanced medical imaging systems, covering both ultrasound and radiology products, and supplies a dedicated line of veterinary products. Founded in 1991, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. maintains its primary operational base in Shenzhen, People's Republic of China.
株価
$26.04
時価総額
$31.56B
変化（1日）
2.25%
変化（1年）
-15.72%
国
CN
取引 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760)
カテゴリー
Healthcare
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（300760）の収益
Jun 2026 時点の収益 TTM: $4.94B
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. の最新の財務報告によると、現在の収益 (TTM) は $4.94B です。2023 年には $4.93B の収益があり、これは 2022 年の $4.40B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. の収益履歴（2014 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $4.94B | -1.85% |
| 2024 | $5.03B | 1.96% |
| 2023 | $4.93B | 12.10% |
| 2022 | $4.40B | 10.72% |
| 2021 | $3.98B | 23.53% |
| 2020 | $3.22B | 35.37% |
| 2019 | $2.38B | 18.91% |
| 2018 | $2.00B | 16.42% |
| 2017 | $1.72B | 32.02% |
| 2016 | $1.30B | 5.42% |
| 2015 | $1.23B | -2.46% |
| 2014 | $1.27B | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.59B | 843.34% |
US
|
|
| $35.48B | 618.54% |
IE
|
|
| $25.84B | 423.19% |
US
|
|
| $21.00B | 325.16% |
US
|
|
| - | - |
DE
|
